Fast-acting human insulin (Adocia)

N/A

Report date: 2023/10/13 20:08:36

Base Information

Drug NameFast-acting human insulin (Adocia)
Drug Alias NameBC-222 human insulinRapid-acting human insulin - AdociaFast-acting human insulin - AdociaHinsBetActrapid +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsCognitive DysfunctionMetabolic SyndromeDiabetes Mellitus, Type 1 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdocia
China Registration ClassN/A

Develop Information

Active CompaniesRutgers University
Inactive CompaniesAdocia
Active IndicationsCognitive DysfunctionMetabolic SyndromeAlzheimer Disease
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A